Pricing Log in Create free account
Saturday 17 October 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IQVIA Holdings Inc. (IQV) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, IQVIA Holdings Inc. (IQV) trades at a price to free cash flow of 19.6×. Over the past ten years it has ranged from 11.0× (May 2025) to 47.1× (June 2019); the current reading is higher than 30% of that period. That is below the Diagnostics & Research industry median of 35.8× and in line with the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 18.2× 9.42%
FY2024 16.7× (41.00%)
FY2023 28.2× 17.07%
FY2022 24.1× 2.79%
FY2021 23.5× (8.08%)
FY2020 25.5× (29.31%)
FY2019 36.1× 21.29%
FY2018 29.8× (17.67%)
FY2017 36.2× 119.37%
FY2016 16.5× (22.33%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 14.2× 8.39%
Mar 2026 13.1× (28.08%)
Dec 2025 18.2× 28.88%
Sep 2025 14.1× 4.99%
42 more quarters

Against its own ten years

Low 11.0× High 47.1×
Ten-year median 24.4×
Current reading's percentile 30

Price to free cash flow against peers

Company Price to free cash flow
DGX Quest Diagnostics Incorporated compare 19.3×
IQV IQVIA Holdings Inc. 19.6×
LH Labcorp Holdings Inc. compare 25.2×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
NTRA Natera, Inc. compare 667×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on IQV